Data / Research funding / Massachusetts / Veramorph LLC
Veramorph LLC: 1 NIH award ($400K) and 1 NSF award ($1.2M)
The full lists. NIH and NSF awards in Massachusetts: 14,447 rows, $224.47. NIH and NSF research awards: 176,803 rows, $1,848.03. $10 of credit on sign-up, no card. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (award ID, organization, city, NIH activity code and assistance listings), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Checked November 10, 2026. Source: NIH RePORTER ExPORTER and NSF Award Search.
Veramorph LLC in Norwood, MA is funded under 1 NIH award ($400K) and 1 NSF award ($1.2M) in the NIH and NSF award files, read 2026-11-10. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
The request: Watch Veramorph LLC: new NIH and NSF awards and the open funding opportunities that match its work.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- JZD1YYDDCLP5
- State
- Massachusetts
Awards
2 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| SBIR Phase II: Design optimization and manufacturing scale-up of oral dosages with environmentally responsive polymers | NSF | Translational Impacts | 2023 | $1,199,999 | September 15, 2023 | May 31, 2025 | Paul D Godfrin | nsf.gov |
| Preclinical validation of an effective oral fulvestrant product as the future standard of care endocrine therapy for ER+ metastatic breast cancer | NIH | National Cancer Institute | 2025 | $399,985 | September 10, 2025 | August 31, 2026 | GODFRIN, PAUL DOUGLAS | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $399,985 | 0 | $0 |
| 2024 | 0 | $0 | 1 | $199,999 |
| 2023 | 0 | $0 | 1 | $1,000,000 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| National Science Foundation Translation to Practice (NSF TTP) | 25-540 | NSF | 47.084 | November 17, 2026 | $2 million | Same assistance listing 47.084 as 1 award here |
| National Science Foundation Fostering Interdisciplinary Networks to Develop Emergent and Responsive Solutions Foundry (NSF FINDERS FOUNDRY) | 26-507 | NSF | 47.084 | November 18, 2026 | Not listed | Same assistance listing 47.084 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.395 | January 7, 2027 | $375,000 | Same assistance listing 93.395 as 1 award here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.395 | January 7, 2027 | $500,000 | Same assistance listing 93.395 as 1 award here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.395 | January 7, 2027 | $499,999 | Same assistance listing 93.395 as 1 award here |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | RFA-CA-27-005 | NIH | 93.395 | January 11, 2027 | $700,000 | Same assistance listing 93.395 as 1 award here |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | PAR-27-009 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) | RFA-CA-26-010 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | RFA-CA-27-003 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| EPSCoR Research Infrastructure Improvement Program: Focused EPSCoR Collaborations (FEC) | 24-573 | NSF | 47.084 | January 26, 2027 | $1.5 million | Same assistance listing 47.084 as 1 award here |
| Major Research Instrumentation Program: (MRI) | 27-500 | NSF | 47.084 | January 29, 2027 | $4 million | Same assistance listing 47.084 as 1 award here |
| Mid-scale Research Infrastructure-1 | 24-598 | NSF | 47.084 | February 8, 2027 | $20 million | Same assistance listing 47.084 as 1 award here |
| EMERGING FRONTIERS IN RESEARCH AND INNOVATION (EFRI-2026/27): Wave-Based Computing ( EFRI-WBC) | 26-524 | NSF | 47.084 | February 11, 2027 | Not listed | Same assistance listing 47.084 as 1 award here |
| Pathways to Enable Secure Open-Source Ecosystems (PESOSE) | 26-506 | NSF | 47.084 | March 2, 2027 | Not listed | Same assistance listing 47.084 as 1 award here |
| NSF Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs: A Pilot Emphasis on Scientific Instrumentation | 26-511 | NSF | 47.084 | March 4, 2027 | Not listed | Same assistance listing 47.084 as 1 award here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.395 | April 5, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.395 | April 5, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| NSF National Quantum Virtual Laboratory (NQVL) | 24-586 | NSF | 47.084 | April 6, 2027 | Not listed | Same assistance listing 47.084 as 1 award here |
Topics of its NIH awards
Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-10). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.
$10 of credit on sign-up, no card.